FindTrial
Sign In

5-methyltetrahydrofolate (5-MTHF)

DIETARY_SUPPLEMENT2 trials

Sponsors

Shenzhen Ausa Pharmed Co.,Ltd, Tabriz University of Medical Sciences

Conditions

HypertensionMASLDMASLD - Metabolic Dysfunction-Associated Steatotic Liver DiseaseMTHFR 677 TT GenotypeMetabolic Dysfunction-Associated Steatotic Liver DiseaseNAFLDNAFLD (Non-alcoholic Fatty Liver Disease)NAFLD (Nonalcoholic Fatty Liver Disease)

Phase 4

China Stroke Primary Prevention Trial 2 for Participants With Hypertension and MTHFR 677 TT Genotype
RecruitingNCT04974151
Shenzhen Ausa Pharmed Co.,LtdHypertension, MTHFR 677 TT Genotype
Start: 2024-08-22End: 2029-06-30Target: 24000Updated: 2025-02-26

Unknown Phase

The Effects of 5-methyltetrahydrofolate Supplementation in Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease
Not yet recruitingNCT07740109
Tabriz University of Medical SciencesMASLD, MASLD - Metabolic Dysfunction-Associated Steatotic Liver Disease, Metabolic Dysfunction-Associated Steatotic Liver Disease +7
Start: 2026-09-30End: 2027-08-30Target: 44Updated: 2026-07-31